-
Signature
-
/s/ Kenneth Weissman (attorney-in-fact for Daniel Manwaring)
-
Issuer symbol
-
IMAX
-
Transactions as of
-
07 Mar 2025
-
Net transactions value
-
-$58,881
-
Form type
-
4/A - Amendment
-
Filing time
-
02 Apr 2025, 16:50:24 UTC
-
Date Of Original Report
-
11 Mar 2025
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
IMAX |
common shares |
Options Exercise |
$0 |
+7,409 |
|
$0.000000 |
7,409 |
07 Mar 2025 |
Direct |
F1 |
| transaction |
IMAX |
common shares |
Tax liability |
$58,881 |
-2,331 |
-31% |
$25.26 |
5,078 |
07 Mar 2025 |
Direct |
F2 |
| holding |
IMAX |
common shares (opening balance) |
|
|
|
|
|
0 |
07 Mar 2025 |
Direct |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
IMAX |
restricted share units |
Options Exercise |
$0 |
+7,409 |
+100% |
$0.000000 |
14,819 |
07 Mar 2025 |
common shares |
7,409 |
$0.000000 |
Direct |
F3, F4, F5, F7 |
| transaction |
IMAX |
restricted share units |
Award |
$0 |
+14,000 |
|
$0.000000 |
14,000 |
07 Mar 2025 |
common shares |
14,000 |
$0.000000 |
Direct |
F3, F4, F6, F7 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
This Form 4/A amends the Form 4 previously filed on March 11, 2025 (the "Original Form 4") solely to correct the number of shares that were withheld by IMAX Corporation to satisfy tax withholding obligations arising from the vesting of Mr. Manwaring's restricted share units and the resulting amount of securities beneficially owned by Mr. Manwaring following such transaction. Accordingly, this Form 4/A amends the Original Form 4 by correcting: (1) the amount appearing on Table I, Column 4, Row 3 from 2,297 to 2,331; (2) the amount appearing on Table I, Column 5, Row 3 from 5,112 to 5,078; and (3) the number of remaining common share balance in footnote 7 from 5,112 to 5,078. The remaining information in the Original Form 4 is not otherwise amended hereby.